Review



microelectronic dna array esensor  (GenMark Diagnostics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenMark Diagnostics microelectronic dna array esensor
    Microelectronic Dna Array Esensor, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microelectronic+dna+array+esensor/microelectronic+dna+array+esensor/pmc11996682-38-36-41
    Average 90 stars, based on 1 article reviews
    microelectronic dna array esensor - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Polymerase Chain Reaction:

    Article Title: Pharmacogenomic Testing in the Clinical Laboratory: Historical Progress and Future Opportunities
    Article Snippet: .. Laboratory-developed tests were offered by a small number of clinical laboratories and utilized a wide variety of techniques, including allele-specific PCR, real-time PCR, a bead-based flow cytometry platform (the Luminex xMAP system, Austin, TX, USA), a microelectronic DNA array (the eSensor, GenMark, Carlsbad, CA, USA), or other simple PCR-based techniques [ – ] (for a review of methods utilized, please see [ ]). .. Microarray technology was also utilized, such as the AmpliChip (Roche, Pleasanton, CA, USA) test for CYP2D6 and CYP2C19 , which was the first FDA-approved pharmacogenetic test [ ].

    Article Title: Pharmacogenomic Testing in the Clinical Laboratory: Historical Progress and Future Opportunities.
    Article Snippet: .. Laboratory-developed tests were offered by a small number of clinical laboratories and utilized a wide variety of techniques, including allele-specific PCR, real-time PCR, a bead-based flow cytometry platform (the Luminex xMAP system, Austin, TX, USA), a microelectronic DNA array (the eSensor, GenMark, Carlsbad, CA, USA), or other simple PCR-based techniques [13–16] (for a review of methods utilized, please see [17]). .. Microarray technology was also utilized, such as the AmpliChip (Roche, Pleasanton, CA, USA) test for CYP2D6 and CYP2C19, which was the first FDA-approved pharmacogenetic test [18].

    Real-time Polymerase Chain Reaction:

    Article Title: Pharmacogenomic Testing in the Clinical Laboratory: Historical Progress and Future Opportunities
    Article Snippet: .. Laboratory-developed tests were offered by a small number of clinical laboratories and utilized a wide variety of techniques, including allele-specific PCR, real-time PCR, a bead-based flow cytometry platform (the Luminex xMAP system, Austin, TX, USA), a microelectronic DNA array (the eSensor, GenMark, Carlsbad, CA, USA), or other simple PCR-based techniques [ – ] (for a review of methods utilized, please see [ ]). .. Microarray technology was also utilized, such as the AmpliChip (Roche, Pleasanton, CA, USA) test for CYP2D6 and CYP2C19 , which was the first FDA-approved pharmacogenetic test [ ].

    Article Title: Pharmacogenomic Testing in the Clinical Laboratory: Historical Progress and Future Opportunities.
    Article Snippet: .. Laboratory-developed tests were offered by a small number of clinical laboratories and utilized a wide variety of techniques, including allele-specific PCR, real-time PCR, a bead-based flow cytometry platform (the Luminex xMAP system, Austin, TX, USA), a microelectronic DNA array (the eSensor, GenMark, Carlsbad, CA, USA), or other simple PCR-based techniques [13–16] (for a review of methods utilized, please see [17]). .. Microarray technology was also utilized, such as the AmpliChip (Roche, Pleasanton, CA, USA) test for CYP2D6 and CYP2C19, which was the first FDA-approved pharmacogenetic test [18].

    Flow Cytometry:

    Article Title: Pharmacogenomic Testing in the Clinical Laboratory: Historical Progress and Future Opportunities
    Article Snippet: .. Laboratory-developed tests were offered by a small number of clinical laboratories and utilized a wide variety of techniques, including allele-specific PCR, real-time PCR, a bead-based flow cytometry platform (the Luminex xMAP system, Austin, TX, USA), a microelectronic DNA array (the eSensor, GenMark, Carlsbad, CA, USA), or other simple PCR-based techniques [ – ] (for a review of methods utilized, please see [ ]). .. Microarray technology was also utilized, such as the AmpliChip (Roche, Pleasanton, CA, USA) test for CYP2D6 and CYP2C19 , which was the first FDA-approved pharmacogenetic test [ ].

    Article Title: Pharmacogenomic Testing in the Clinical Laboratory: Historical Progress and Future Opportunities.
    Article Snippet: .. Laboratory-developed tests were offered by a small number of clinical laboratories and utilized a wide variety of techniques, including allele-specific PCR, real-time PCR, a bead-based flow cytometry platform (the Luminex xMAP system, Austin, TX, USA), a microelectronic DNA array (the eSensor, GenMark, Carlsbad, CA, USA), or other simple PCR-based techniques [13–16] (for a review of methods utilized, please see [17]). .. Microarray technology was also utilized, such as the AmpliChip (Roche, Pleasanton, CA, USA) test for CYP2D6 and CYP2C19, which was the first FDA-approved pharmacogenetic test [18].

    DNA Array:

    Article Title: Pharmacogenomic Testing in the Clinical Laboratory: Historical Progress and Future Opportunities
    Article Snippet: .. Laboratory-developed tests were offered by a small number of clinical laboratories and utilized a wide variety of techniques, including allele-specific PCR, real-time PCR, a bead-based flow cytometry platform (the Luminex xMAP system, Austin, TX, USA), a microelectronic DNA array (the eSensor, GenMark, Carlsbad, CA, USA), or other simple PCR-based techniques [ – ] (for a review of methods utilized, please see [ ]). .. Microarray technology was also utilized, such as the AmpliChip (Roche, Pleasanton, CA, USA) test for CYP2D6 and CYP2C19 , which was the first FDA-approved pharmacogenetic test [ ].

    Article Title: Pharmacogenomic Testing in the Clinical Laboratory: Historical Progress and Future Opportunities.
    Article Snippet: .. Laboratory-developed tests were offered by a small number of clinical laboratories and utilized a wide variety of techniques, including allele-specific PCR, real-time PCR, a bead-based flow cytometry platform (the Luminex xMAP system, Austin, TX, USA), a microelectronic DNA array (the eSensor, GenMark, Carlsbad, CA, USA), or other simple PCR-based techniques [13–16] (for a review of methods utilized, please see [17]). .. Microarray technology was also utilized, such as the AmpliChip (Roche, Pleasanton, CA, USA) test for CYP2D6 and CYP2C19, which was the first FDA-approved pharmacogenetic test [18].



    Similar Products

    microelectronic dna array esensor  (GenMark Diagnostics)
    90
    GenMark Diagnostics microelectronic dna array esensor
    Microelectronic Dna Array Esensor, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microelectronic+dna+array+esensor/microelectronic+dna+array+esensor/pmc11996682-38-36-41
    Average 90 stars, based on 1 article reviews
    microelectronic dna array esensor - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results